ARTERIUS LIMITED

Active Leeds

Other research and experimental development on natural sciences and engineering

8 employees website.com
Life sciences and medical technology Other research and experimental development on natural sciences and engineering
A

ARTERIUS LIMITED

Other research and experimental development on natural sciences and engineering

Founded 5 Aug 2009 Active Leeds, England 8 employees website.com
Life sciences and medical technology Other research and experimental development on natural sciences and engineering
Accounts Submitted 7 Nov 2025 Next due 31 Dec 2026 8 months remaining
Confirmation Submitted 9 Feb 2026 Next due 13 Feb 2027 9 months remaining
Net assets £3M £579K 2024 year on year
Total assets £3M £525K 2024 year on year
Total Liabilities £111K £54K 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

Mayesbrook House Lawnswood Business Park Redvers Close Leeds West Yorkshire LS16 6QY England

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for ARTERIUS LIMITED (06981739), an active life sciences and medical technology company based in Leeds, England. Incorporated 5 Aug 2009. Other research and experimental development on natural sciences and engineering. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2015–2024)

Cash in Bank

£70.80k

Decreased by £730.82k (-91%)

Net Assets

£2.88M

Decreased by £578.66k (-17%)

Total Liabilities

£110.71k

Increased by £53.87k (+95%)

Turnover

N/A

Employees

8

Decreased by 4 (-33%)

Debt Ratio

4%

Increased by 2 (+100%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Grants 3

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

9 Allotments 733,224 Shares £1.27m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
28 Jul 2016228£40k£1k
28 May 2025552,995£600k£1.085
14 Dec 20179£15k£2k
11 Dec 201742£70k£2k
21 Nov 2017122,950£205k£1.665

Officers

Officers

1 active 2 resigned
Status
Michal SobierajDirectorPolishUnited Arab Emirates4425 Jun 2025Active

Shareholders

Shareholders (18)

Bulb Holdings Ltd
29.0%
1,570,396
Novoline Doo
19.2%
1,041,000

Persons with Significant Control

Persons with Significant Control (0)

0 Active 2 Ceased

Kadem Al-lamee

Ceased 23 Sept 2021

Ceased

Novoline Doo

Ceased 23 Sept 2021

Ceased

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
18 Apr 2026ResolutionResolutions
1 Apr 2026CapitalAllotment of shares (GBP 5,846.85) on 2026-03-25
9 Feb 2026Confirmation StatementConfirmation statement made on 2026-01-30 with updates
9 Feb 2026OfficersChange to director Mr Peter James Mason on 2026-02-09
6 Feb 2026OfficersChange to director Mr Barry Clare on 2026-02-06
18 Apr 2026 Resolution

Resolutions

1 Apr 2026 Capital

Allotment of shares (GBP 5,846.85) on 2026-03-25

9 Feb 2026 Confirmation Statement

Confirmation statement made on 2026-01-30 with updates

9 Feb 2026 Officers

Change to director Mr Peter James Mason on 2026-02-09

6 Feb 2026 Officers

Change to director Mr Barry Clare on 2026-02-06

Recent Activity

Latest Activity

Resolutions

3 days ago on 18 Apr 2026

Allotment of shares (GBP 5,846.85) on 2026-03-25

2 weeks ago on 1 Apr 2026

Confirmation statement made on 2026-01-30 with updates

2 months ago on 9 Feb 2026

Change to director Mr Peter James Mason on 2026-02-09

2 months ago on 9 Feb 2026

Change to director Mr Barry Clare on 2026-02-06

2 months ago on 6 Feb 2026